X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1833) 1833
Publication (291) 291
Patent (21) 21
Conference Proceeding (17) 17
Book Review (13) 13
Book / eBook (12) 12
Book Chapter (6) 6
Magazine Article (4) 4
Data Set (1) 1
Dissertation (1) 1
Paper (1) 1
Report (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (984) 984
index medicus (803) 803
male (677) 677
female (617) 617
adult (452) 452
middle aged (448) 448
infectious diseases (300) 300
aged (268) 268
risk factors (236) 236
animals (231) 231
immunology (216) 216
research (214) 214
health aspects (167) 167
analysis (159) 159
hiv (156) 156
netherlands (151) 151
research article (135) 135
treatment outcome (132) 132
hiv infections - drug therapy (130) 130
adolescent (127) 127
microbiology (127) 127
article (126) 126
medicine (125) 125
medicine, general & internal (116) 116
care and treatment (114) 114
cohort studies (112) 112
mortality (112) 112
virology (108) 108
studies (107) 107
young adult (107) 107
aged, 80 and over (104) 104
prospective studies (103) 103
drug therapy (101) 101
mice (97) 97
human immunodeficiency virus--hiv (95) 95
viral load (95) 95
risk (92) 92
multidisciplinary sciences (88) 88
time factors (87) 87
usage (86) 86
disease (85) 85
infections (85) 85
infection (84) 84
epidemiology (83) 83
incidence (81) 81
prevalence (81) 81
science (79) 79
antiretroviral therapy (78) 78
hiv infections - virology (78) 78
netherlands - epidemiology (78) 78
therapy (77) 77
aids (76) 76
abridged index medicus (75) 75
management (75) 75
cd4 lymphocyte count (74) 74
hematology (74) 74
oncology (74) 74
diagnosis (73) 73
cancer (70) 70
medicine & public health (70) 70
peripheral vascular disease (70) 70
hiv infection (69) 69
surgery (69) 69
patients (68) 68
prevention (68) 68
medical research (64) 64
pharmacology & pharmacy (63) 63
anti-hiv agents - therapeutic use (60) 60
expression (60) 60
follow-up studies (60) 60
surveys and questionnaires (59) 59
hiv-1 (58) 58
disease progression (57) 57
genetics (57) 57
proteins (57) 57
retrospective studies (57) 57
aids/hiv (56) 56
hiv infections - immunology (56) 56
public, environmental & occupational health (56) 56
drug therapy, combination (55) 55
genetic aspects (55) 55
genetics & heredity (54) 54
public health (54) 54
child (53) 53
human-immunodeficiency-virus (53) 53
life sciences (53) 53
mutation (53) 53
hiv infections - epidemiology (52) 52
men (52) 52
virus diseases (52) 52
prognosis (51) 51
hiv infections - complications (50) 50
internal medicine (50) 50
journal article (50) 50
population (50) 50
rats (49) 49
thromboembolism (49) 49
cell biology (48) 48
clinical trials (48) 48
physiological aspects (48) 48
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1892) 1892
Dutch (17) 17
French (9) 9
German (3) 3
Japanese (3) 3
Portuguese (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article